Is Link Pharma Chem Ltd (524748) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Link Pharma Chem Ltd is a average quality company .

Is Link Pharma Chem Ltd (524748) undervalued or overvalued?

The key valuation ratios of Link Pharma Chem Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Link Pharma Chem Ltd (524748) share price return in the past 10 years?

Link Pharma Chem Ltd share price has appreciated 13.3% annually (CAGR) over the past ten years.

Is Link Pharma Chem Ltd (524748) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Link Pharma Chem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Link Pharma Chem Ltd (524748)?

Company share prices are keep on changing according to the market conditions. The current trading price of Link Pharma Chem Ltd (524748) on 30-Apr-2026 16:59:59 at 16:59 is 29.76.

What is the P/E ratio of Link Pharma Chem?

The latest standalone P/E ratio of Link Pharma Chem as of 30-Apr-2026 is 98.62.

What is the P/B ratio of Link Pharma Chem Ltd (524748)?

The latest standalone P/B ratio of Link Pharma Chem Ltd (524748) as of 30-Apr-2026 is 1.01.

What is the 52-week high and low of Link Pharma Chem Ltd (524748)?

The 52-week high of Link Pharma Chem Ltd (524748) is Rs. 42.80 and the 52-week low is Rs. 21.00.

Link Pharma Chem Ltd (524748) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Link Pharma Chem Ltd (524748)
Brand: Link Pharma Chem

Link Pharma Chem Ltd (524748) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹13 Cr.

P/E Ratio

98.62

Price to Book (P/B)

1.01

Price to Sales (P/S)

0.48

EV/EBITDA

12.11

Return on Capital Employed (ROCE)

-3.03%

Current Price

₹29.8

Return on Equity (ROE)

-7.79%

Return on Assets (ROA)

-4.19%

Operating Profit Margin

0.5%

Net Profit Margin

-4.04%

Gross Profit Margin

-1.8%

Book Value per Share

₹29.6

Sales Growth (YoY)

-14.95%

Sales Growth (3 Years)

-21.99%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

-65.62%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹21 / 43

Net Profit Growth (3 Years)

NAN%

Dividend Yield

0.00%

Promoter Holding

52.40%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Link Pharma Chem Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 13.3% based on the current price.

Q.1 Revenue growth of Link Pharma Chem Ltd?

Link Pharma Chem Ltd revenue growth is -15% for FY-2025, which is below its 5-year CAGR of -0.03%, indicating slower growth.

Q.1 Which industry/sub-sector does Link Pharma Chem Ltd belong to?

Link Pharma Chem Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.1 Promoter shareholding and pledge status of Link Pharma Chem Ltd?

Promoters hold 52.40% of the Link Pharma Chem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Link Pharma Chem Ltd vs industry peers?

Link Pharma Chem Ltd revenue CAGR is -0.03%, compared to the industry median CAGR of 9.62%, indicating slower growth and losing its market share.

DeciZen - make an informed investing decision on Link Pharma Chem

Based on:

Data

M-Cap below 100cr DeciZen not available

ink Pharma Chem stock performance

Key Ratios

Is Link Pharma Chem Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	9.8%	9.3%	15.4%	10.3%	12.9%	13.6%	16.6%	7.4%	-4.5%	-3%	-
Value Creation Index ⓘ	-0.3	-0.3	0.1	-0.3	-0.1	0.0	0.2	-0.5	-1.3	-1.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	12.3	16.1	23.5	24.5	25.5	34.8	53.6	38.8	29.9	25.4	27
Sales YoY Gr.	-	30.5%	46.2%	4.1%	4%	36.7%	53.9%	-27.6%	-22.9%	-15%	-
Adj EPS ⓘ	-2.8	1.3	2.6	1.4	3.4	2.7	3.6	1.9	-3.2	-2.4	0.3
YoY Gr.	-	NA	96.2%	-45.1%	140%	-19.6%	34.8%	-48.4%	-270.2%	NA	-
BVPS (₹) ⓘ	20.2	19.4	22.1	23.4	25.8	28.3	32.6	33.9	30.9	28.5	29.6
Adj Net Profit ⓘ	-1.2	0.6	1.1	0.6	1.5	1.2	1.6	0.8	-1.4	-1.1	0
Cash Flow from Ops. ⓘ	-3.9	2.2	3.8	1.4	3	4.8	-1.3	-1.7	-0	2.7	-
Debt/CF from Ops. ⓘ	-1.4	2.1	0.7	1.9	1.2	0.8	-5.1	-5.1	-329.4	2.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	8.4%	-0%	-22%	-15%
Adj EPS ⓘ	NA	-193.2%	-186.6%	NA
BVPSⓘ	3.9%	2.1%	-4.4%	-7.6%
Share Price	13.3%	-1.5%	-9.4%	-15.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-14.3	6.6	12.3	6.2	13.7	10	12	5.7	-9.9	-7.9	1
Op. Profit Mgn % ⓘ	-1.3	15.8	11.8	8.2	13.4	9	6.5	7	-2.2	0.5	5.3
Net Profit Mgn % ⓘ	-10	3.6	4.8	2.5	5.9	3.4	3	2.2	-4.8	-4.1	0.5
Debt to Equity ⓘ	0.6	0.6	0.3	0.3	0.3	0.3	0.4	0.6	0.7	0.5	-
Working Cap Days ⓘ	200	148	111	115	117	108	92	161	199	177	83
Cash Conv. Cycle ⓘ	119	76	32	35	35	20	22	68	115	117	11

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.3	-
TTM Sales (₹ Cr.)	27.3	-
BVPS (₹) ⓘ	29.6	-
Reserves (₹ Cr.) ⓘ	9	-
P/BV ⓘ	1.01	-
PE ⓘ	98.62	-

From the Market
52 Week Low / High (₹)	21.00 / 42.80
All Time Low / High (₹)	0.84 / 75.00
Market Cap (₹ Cr.)	13.2
Equity (₹ Cr.)	4.4
Face Value (₹)	10
Industry PE ⓘ	46.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Link Pharma Chem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	12.34	16.10	23.53	24.50	25.47	34.81	53.56	38.76	29.90	25.43
Operating Expenses ⓘ +	12.50	14.08	20.76	22.48	22.87	31.85	50.36	36.45	30.55	25.30
Manufacturing Costs	3.35	3.75	4.32	4.85	6.10	6.86	6.29	7.11	6.54	5.84
Material Costs	4.84	5.45	9.90	11.33	9.91	17.78	36.43	21.37	16.68	12.54
Employee Cost	2.79	3.60	4.90	4.72	4.99	5.63	5.77	5.69	5.52	5.39
Other Costs ⓘ	1.53	1.28	1.64	1.59	1.88	1.58	1.86	2.29	1.81	1.53
Operating Profit ⓘ	-0.16	2.02	2.78	2.02	2.60	2.97	3.20	2.31	-0.65	0.13
Operating Profit Margin (%)	-1.3%	12.5%	11.8%	8.2%	10.2%	8.5%	6.0%	6.0%	-2.2%	0.5%
Other Income ⓘ +	2.74	0.09	0.07	0.19	0.13	0.03	0.80	0.26	0.64	0.19
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.91	0.80	0.62	0.39	0.36	0.44	0.45	0.76	0.87	0.78
Depreciation ⓘ	0.93	0.83	0.86	0.89	0.93	0.87	0.93	0.92	1.03	0.94
Profit Before Tax ⓘ	0.74	0.48	1.37	0.93	1.44	1.68	2.62	0.89	-1.92	-1.40
Tax ⓘ	0.15	0.26	0.24	0.27	0.49	0.59	0.74	0.23	-0.55	-0.38
Profit After Tax	0.59	0.23	1.13	0.66	0.95	1.08	1.88	0.65	-1.36	-1.03
PAT Margin (%)	4.8%	1.4%	4.8%	2.7%	3.7%	3.1%	3.5%	1.7%	-4.6%	-4.0%
Adjusted EPS (₹)	1.3	0.5	2.6	1.5	2.1	2.4	4.2	1.5	-3.1	-2.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	8.96	8.60	9.79	10.38	11.43	12.56	14.47	15.04	13.71	12.66
Share Capital ⓘ	4.44	4.44	4.44	4.44	4.44	4.44	4.44	4.44	4.44	4.44
Reserves ⓘ	4.52	4.16	5.35	5.94	6.99	8.12	10.03	10.60	9.27	8.22
Debt +	5.08	4.50	2.43	2.36	3.17	3.16	5.49	7.77	8.88	5.54
Long Term Debt	1.75	1.18	2.25	1.71	3.17	3.16	2.90	1.98	1.06	0.42
Short Term Debt	3.32	3.32	0.19	0.66	0	0	2.58	5.79	7.82	5.12
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	1.08	3.03	3.37	3.37	3.01	6.85	4.53	6.61	1.76	3.48
Others Liabilities ⓘ	2.43	1.01	1.60	1.89	1.36	3.47	4.48	3.04	1.61	1.38
Total Liabilities ⓘ	17.55	17.14	17.19	18	18.97	26.04	28.96	32.46	25.95	23.06
Fixed Assets
Net Fixed Assets ⓘ +	10.13	9.57	9.76	9.14	8.81	8.71	8.79	9	9.94	9.28
Gross Block	15.13	10.40	11.43	11.58	11.56	11.74	12.74	13.88	15.66	15.95
Accumulated Depreciation	4.99	0.83	1.67	2.45	2.76	3.03	3.95	4.88	5.73	6.67
CWIP ⓘ	0	0	0.01	0.43	0	0	0.21	0	0	0
Investments ⓘ	0.02	0.03	0.03	0.03	0.03	0.03	4.52	3.64	2.93	2.06
Inventories	3.67	4.27	2.63	2.87	1.63	2.50	4.76	12.25	6.21	5.74
Trade Receivables	2.33	2.18	3.18	3.04	4.99	5.55	5.37	3.63	5.15	5.02
Cash Equivalents	0.27	0.18	0.18	0.20	2.05	4.86	0.88	0.20	0.09	0.06
Others Assets ⓘ	1.13	0.92	1.39	2.30	1.45	4.40	4.45	3.74	1.63	0.91
Total Assets ⓘ	17.55	17.14	17.19	18	18.97	26.04	28.96	32.46	25.95	23.06

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-3.91	2.23	3.79	1.36	2.95	4.84	-1.26	-1.71	-0.03	2.69
PBT ⓘ	0.74	0.48	1.37	0.93	1.44	1.68	2.62	0.89	-1.92	-1.40
Adjustment ⓘ	-0.43	2.13	1.47	1.26	2.04	1.46	0.96	2.25	1.37	1.53
Changes in Working Capital ⓘ	-4.12	-0.28	1.25	-0.63	-0.64	2.18	-4.16	-4.43	0.89	2.53
Tax Paid ⓘ	-0.10	-0.10	-0.30	-0.20	0.11	-0.48	-0.67	-0.41	-0.37	0.03
Cash Flow From Investing Activity ⓘ +	8.72	-0.73	-1.15	-0.96	-1.66	-2.16	-4.97	-0.08	0.41	1.53
Capex	8.71	-0.86	-1.16	-0.87	-1.68	-1.70	-0.74	-0.89	-0.83	-0.26
Net Investments	0	0.10	0.01	-0.09	-0.05	-0.45	-4.32	0.67	1.15	1.72
Others ⓘ	0.02	0.03	0	0	0.07	-0.01	0.10	0.15	0.08	0.06
Cash Flow From Financing Activity ⓘ +	-5.75	-1.48	-2.63	-0.46	0.55	-0.33	2.27	1.61	-0.41	-4.21
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0.14	-0.84	-1.56	-0.74
Interest Paid ⓘ	-0.91	-0.80	-0.62	-0.39	-0.36	-0.44	-0.45	-0.76	-0.87	-0.78
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-4.84	-0.68	-2.02	-0.07	0.91	0.11	2.58	3.20	2.03	-2.70
Net Cash Flow ⓘ	-0.94	0.02	0	-0.05	1.85	2.35	-3.95	-0.17	-0.03	0

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	6.83	2.58	12.34	6.53	8.71	9.04	13.92	4.43	-9.48	-7.79
ROCE (%)	9.83	9.26	15.38	10.31	12.87	13.58	16.57	7.38	-4.47	-3.03
Asset Turnover Ratio	0.61	1.03	1.4	1.39	1.38	1.55	1.95	1.26	1.02	1.04
PAT to CFO Conversion(x)	-6.63	9.7	3.35	2.06	3.11	4.48	-0.67	-2.63	N/A	N/A
Working Capital Days
Receivable Days	73.80	46.20	40.80	46.40	57.60	55.30	37.20	42.40	53.60	73
Inventory Days	101.30	81.30	52.60	41	32.30	21.60	24.70	80.10	112.70	85.70
Payable Days	147.50	137.70	118	108.60	117.50	101.20	57	95.10	91.50	76.20

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Link Pharma Chem Ltd FAQs

The current trading price of Link Pharma Chem on 30-Apr-2026 16:59 is ₹29.76.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Apr-2026 the market cap of Link Pharma Chem stood at ₹13.22 Cr

The latest P/E ratio of Link Pharma Chem as of 29-Apr-2026 is 98.62.

The latest P/B ratio of Link Pharma Chem as of 29-Apr-2026 is 1.01.

The 52-week high of Link Pharma Chem is ₹42.80 and the 52-week low is ₹21.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Link Pharma Chem is ₹27.29 ( Cr.) .

About Link Pharma Chem Ltd

Link Pharma Chem, incorporated on December 28, 1984 is a manufacturer of thionyl chloride.

The company manufactures thionyl chloride and other inorganic chemical intermediates at its plants located in the Baroda and Ankleshwar districts of Gujarat with an installed capacity of 2,100 TPA. In FY08, the company received an international grant from United Nations Industrial Development Organization of Rs 7.7 million for phasing out a carbon tetra chloride product as raw material, which was implemented. The company plans to develop the acquired land in the Baroda district and has purchased a 10,800 sq. m. plot with RCC building of approximately 50,000 sq. ft. constructed area from DRT Ahmedabad for Rs 14 million for diversification projects.

Link Pharma Chem has, over the years, followed the best business practices. The company believes that good corporate governance is essential to achieve long-term corporate goals and to enhance stakeholders' value. In this pursuit, the company is committed to conducting business in accordance with the highest legal and ethical standard, superior product quality and services to its customers. All employees are bound by a code of conduct, which sets forth the company's policies on important issues, including relationship with customers, vendors and the government.

Business areas of the company:

The company manufactures thionyl chloride and other inorganic chemical intermediates at its plants located in the Baroda and Ankleshwar districts of Gujarat with an installed capacity of 2,100 TPA.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Link Pharma Chem Ltd (524748) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Link Pharma Chem Share Price